43
Markets4h 48m ago

Harbour BioMed and BioMap today announced a multi-dimensional, long-term strategic partnership centered on AI-driven discovery and development of complex biologics.

Archive Window: 7 Days Left

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI

Who
Harbour BioMed (HKEX: 02142.HK) and BioMap
What
Harbour BioMed and BioMap today announced a multi-dimensional, long-term strategic partnership centered on AI-driven discovery and development of complex biologics.
When
Mon, 15 Jun 2026 12:35:23 GMT · 4h 48m ago
Where
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI ·
Why
The alliance aims to systematically overcome critical bottlenecks constraining next-generation innovative therapies and to build a globally competitive, AI-powered R&D ecosystem.
The Frontline Impact

How this affects you

This collaboration could significantly accelerate the development of new biologic drugs across various disease areas by integrating advanced AI models with deep biological expertise, potentially leading to more efficient drug discovery and development processes.

Story chain

2 events in this thread
  1. Currently Reading4h 48m ago
    Harbour BioMed and BioMap today announced a multi-dimensional, long-term strategic partnership centered on AI-driven discovery and development of complex biologics.
  2. Markets4h 48m ago
    Harbour BioMed and BioMap announced a strategic partnership to launch MegaStream TechBio, an AI-native pipeline company focusing on AI-driven discovery and development of complex biologics.
    Open article

Verified Sources & Citations